We need to know when to start treatment, how well the treatment is working, and when we might be able to stop treatment. Many major advances have been made in measuring our amount of disease, now giving us the ability to look for minimal amounts of residual disease (MRD) down to being able to detect one cancer cell among a million normal cells.